Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias
Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
This is a 41-week trial composed of two consecutive parts (Part A, 14 weeks and optional Part
B, 27 weeks) to evaluate the efficacy of levetiracetam in controlling levodopa induced
dyskinesias in adults with Idiopathic Parkinson's Disease, without negative impact on the
benefit on the motor function of the antiparkinsonian treatment.